Enlivex Ltd.
ENLV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596812
No open-market purchases or sales by Enlivex Ltd. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $2.34M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in Enlivex Ltd. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −5 vs. Q1 2025
- Shares held
- 2.56M
- −610.4K (−19.2%) vs. Q1 2025
- Total value
- $2.87M
- −$207.0K (−6.7%) vs. Q1 2025
- New holders
- 3
- 2 more added
- Sold out
- 8
- 7 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENLV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $2.34M |
| Q1 2026 | 35 | $3.38M |
| Q4 2025 | 25 | $929.4K |
| Q3 2025 | 29 | $950.2K |
| Q2 2025 | 21 | $2.87M |
| Q1 2025 | 26 | $3.08M |
| Q4 2024 | 24 | $3.99M |
| Q3 2024 | 19 | $4.31M |
| Q2 2024 | 17 | $2.96M |
| Q1 2024 | 15 | $1.24M |
| Q4 2023 | 17 | $509.2K |
| Q3 2023 | 16 | $408.4K |
| Q2 2023 | 19 | $795.1K |
| Q1 2023 | 19 | $1.24M |
| Q4 2022 | 21 | $1.32M |
| Q3 2022 | 18 | $1.41M |
| Q2 2022 | 22 | $2.89M |
| Q1 2022 | 25 | $4.75M |
| Q4 2021 | 23 | $4.12M |
| Q3 2021 | 20 | $8.38M |
| Q2 2021 | 20 | $8.79M |
| Q1 2021 | 23 | $11.7M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Enlivex Ltd.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 1,413,306 | $1.58M | 0.06% | −368,625−20.7% | Reduced |
| Millennium Management LLC | 612,200 | $685.7K | 0.00% | −56,808−8.5% | Reduced |
| Morgan Stanley | 219,149 | $245.4K | 0.00% | −11,536−5.0% | Reduced |
| Renaissance Technologies LLC | 168,392 | $188.6K | 0.00% | −12,897−7.1% | Reduced |
| Jane Street Group, LLC | 61,052 | $68.4K | 0.00% | −19,707−24.4% | Reduced |
| Sigma Investment Counselors Inc | 28,000 | $31.4K | 0.00% | 00.0% | Unchanged |
| Neuberger Berman Group LLC | 10,988 | $12.3K | 0.00% | −3,012−21.5% | Reduced |
| SkyView Investment Advisors, LLC | 10,000 | $12.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 9,184 | $10.3K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 7,142 | $8.00K | 0.00% | +405+6.0% | Added |
| Group One Trading, L.P. | 7,000 | $7.84K | 0.00% | +7,000 | New |
| Signaturefd, LLC | 5,000 | $5.60K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 3,044 | $3.41K | 0.00% | +2,824+1,283.6% | Added |
| Steward Partners Investment Advisory, LLC | 2,500 | $2.80K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,814 | $2.03K | 0.00% | −99−5.2% | Reduced |
| SRS Capital Advisors, Inc. | 1,015 | $1.14K | 0.00% | 00.0% | Unchanged |
| BFSG, LLC | 1,000 | $1.12K | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 1,000 | $1.12K | 0.00% | 00.0% | Unchanged |
| Spire Wealth Management | 500 | $560 | 0.00% | +500 | New |
| Red Tortoise LLC | 150 | $168 | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 57 | $64 | 0.00% | +57 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −70,136−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −28,390−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,451−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,833−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −10,420−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,178−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,063−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −16−100.0% | Sold out |